Analysis of masked mutations in familial adenomatous polyposis

被引:78
作者
Laken, SJ
Papadopoulos, N
Petersen, GM
Gruber, SB
Hamilton, SR
Giardiello, FM
Brensinger, JD
Vogelstein, B
Kinzler, KW
机构
[1] Howard Hughes Med Inst, Baltimore, MD 21231 USA
[2] Johns Hopkins Oncol Ctr, Baltimore, MD 21231 USA
[3] Columbia Univ, Coll Phys & Surg, Dept Pathol, New York, NY 10032 USA
[4] Johns Hopkins Univ, Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21205 USA
[5] Univ Michigan, Div Med & Mol Genet, Ann Arbor, MI 48109 USA
[6] MD Anderson Canc Ctr, Div Pathol & Lab Med, Houston, TX 77030 USA
[7] Johns Hopkins Hosp, Dept Med, Baltimore, MD 21287 USA
关键词
D O I
10.1073/pnas.96.5.2322
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Familial adenomatous polyposis (FAP) is an autosomal-dominant disease characterized by the development of hundreds of adenomatous polyps of the colorectum. Approximately 80% of FAP patients can be shown to have truncating mutations of the APC gene. To determine the cause of FAP in the other 20% of patients, MAMA (monoallelic mutation analysis) was used to independently examine the status of each of the two APC alleles. Seven of nine patients analyzed mere found to have significantly reduced expression from one of their two alleles whereas two patients were found to have full-length expression from both alleles. We conclude that more than 95% of patients with FAP have inactivating mutations in APC and that a combination of MAMA and standard genetic tests will identify APC abnormalities in the vast majority of such patients. That no APC expression from the mutant allele is found in some FAP patients argues strongly against the requirement for dominant negative effects of APC mutations. The results also suggest that there may be at least one additional gene, besides APC, that can give rise to FAP.
引用
收藏
页码:2322 / 2326
页数:5
相关论文
共 41 条
[21]   LINKAGE STUDIES IN ITALIAN FAMILIES WITH FAMILIAL ADENOMATOUS POLYPOSIS [J].
MARENI, C ;
STELLA, A ;
ORIGONE, P ;
SUSCA, F ;
MONTERA, MP ;
LONOCE, A ;
DELEON, MP ;
SASSATELLI, R ;
GENTILE, M ;
STRAFACE, A ;
CARUSO, ML ;
PALASCIANO, N ;
AJMAR, F ;
GUANTI, G .
HUMAN GENETICS, 1993, 90 (05) :545-550
[22]   INSERTION DELETION POLYMORPHISM AND OTHER RESTRICTION-FRAGMENT-LENGTH-POLYMORPHISMS IN THE MCC GENE [J].
MIYOSHI, Y ;
NISHISHO, I ;
MIKI, Y ;
MORI, T ;
KINZLER, KW ;
VOGELSTEIN, B ;
NAKAMURA, Y .
JAPANESE JOURNAL OF CANCER RESEARCH, 1992, 83 (01) :10-14
[23]   XTcf-3 transcription factor mediates beta-catenin-induced axis formation in Xenopus embryos [J].
Molenaar, M ;
vandeWetering, M ;
Oosterwegel, M ;
PetersonMaduro, J ;
Godsave, S ;
Korinek, V ;
Roose, J ;
Destree, O ;
Clevers, H .
CELL, 1996, 86 (03) :391-399
[24]   Activation of beta-catenin-Tcf signaling in colon cancer by mutations in beta-catenin or APC [J].
Morin, PJ ;
Sparks, AB ;
Korinek, V ;
Barker, N ;
Clevers, H ;
Vogelstein, B ;
Kinzler, KW .
SCIENCE, 1997, 275 (5307) :1787-1790
[25]   REGULATION OF INTRACELLULAR BETA-CATENIN LEVELS BY THE ADENOMATOUS POLYPOSIS-COLI (APC) TUMOR-SUPPRESSOR PROTEIN [J].
MUNEMITSU, S ;
ALBERT, I ;
SOUZA, B ;
RUBINFELD, B ;
POLAKIS, P .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (07) :3046-3050
[26]  
NAGASE H, 1992, CANCER RES, V52, P4055
[27]   MUTATIONS OF THE APC (ADENOMATOUS POLYPOSIS-COLI) GENE [J].
NAGASE, H ;
NAKAMURA, Y .
HUMAN MUTATION, 1993, 2 (06) :425-434
[28]  
Nakagawa H, 1998, CANCER RES, V58, P5176
[29]   Axin, an inhibitor of the Wnt signalling pathway, interacts with β-catenin, GSK-3β and APC and reduces the β-catenin level [J].
Nakamura, T ;
Hamada, F ;
Ishidate, T ;
Anai, K ;
Kawahara, K ;
Toyoshima, K ;
Akiyama, T .
GENES TO CELLS, 1998, 3 (06) :395-403
[30]   MONOALLELIC MUTATION ANALYSIS (MAMA) FOR IDENTIFYING GERMLINE MUTATIONS [J].
PAPADOPOULOS, N ;
LEACH, FS ;
KINZLER, KW ;
VOGELSTEIN, B .
NATURE GENETICS, 1995, 11 (01) :99-102